[1] Zhou M, Wang H, Zhu J, Chen W, Wang L, Liu S, Li Y, Wang L, Liu Y, Yin P, Liu J, Yu S, Tan F, Barber RM, Coates MM, Dicker D, Fraser M, González-Medina D, Hamavid H, Hao Y, Hu G, Jiang G, Kan H, Lopez AD, Phillips MR, She J, Vos T, Wan X, Xu G, Yan LL, Yu C, Zhao Y, Zheng Y, Zou X, Naghavi M, Wang Y, Murray CJ, Yang G, Liang X. Cause-specific mortality for 240 causes in China during 1990-2013:a systematic subnational analysis for the Global Burden of Disease Study 2013[J]. Lancet, 2016, 387:251-272. [2] Lawrence ES, Coshall C, Dundas R, Stewart J, Rudd AG, Howard R, Wolfe CD. Estimates of the prevalence of acute stroke impairments and disability in a multiethnic population[J]. Stroke, 2001, 32:1279-1284. [3] Zhang H, Li CL, Wan F, Wang SJ, Wei XE, Hao YL, Leng HL, Li JM, Yan ZR, Wang BJ, Xu RS, Yu TM, Zhou LC, Fan DS. Efficacy of cattle encephalon glycoside and ignotin in patients with acute cerebral infarction:a randomized, double-blind, parallel-group, placebo-controlled study[J]. Neural Regen Res, 2020, 15:1266-1273. [4] Dai YW, Chen YS. Progress on Peroxiredoxin triggers cerebral post-ischemic inflammation[J]. Shen Jing Ji Bing Yu Jing Shen Wei Sheng, 2015, 15:94-96.[戴永武, 陈煜森. Peroxiredoxin触发脑缺血后炎性反应的机制[J]. 神经疾病与精神卫生, 2015, 15:94-96.] [5] Gong X, Zou X, Liu L, Pu Y, Wang Y, Pan Y, Soo YO, Leung TW, Zhao X, Wang Y, Wong KS. Prognostic value of inflammatory mediators in 1-year outcome of acute ischemic stroke with middle cerebral artery stenosis[J]. Mediators Inflamm, 2013:ID850714. [6] Sucharew H, Khoury J, Moomaw CJ, Alwell K, Kissela BM, Belagaje S, Adeoye O, Khatri P, Woo D, Flaherty ML, Ferioli S, Heitsch L, Broderick JP, Kleindorfer D. Profiles of the National Institutes of Health Stroke Scale items as a predictor of patient outcome[J]. Stroke, 2013, 44:2182-2187. [7] Wei W, Li S, San F, Zhang S, Shen Q, Guo J, Zhang L. Retrospective analysis of prognosis and risk factors of patients with stroke by TOAST[J]. Medicine (Baltimore), 2018, 97:e0412. [8] Sykora M, Krebs S, Simader F, Gattringer T, Greisenegger S, Ferrari J, Bernegger A, Posekany A, Lang W; Austrian Stroke Unit Registry Collaborators. Intravenous thrombolysis in stroke with admission NIHSS score 0 or 1[J]. Int J Stroke, 2022, 17:109-119. [9] Braksick SA, Wijdicks EFM. An NIHSS of 0 and a very disabling stroke[J]. Neurocrit Care, 2017, 26:444-445. [10] Yaghi S, Willey JZ, Andrews H, Boehme AK, Marshall RS, Boden-Albala B. The itemized NIHSS scores are associated with discharge disposition in patients with minor stroke[J]. Neurohospitalist, 2016, 6:102-106. [11] Neurology Branch, Chinese Medical Association; Cerebrovascular Disease Group, Neurology Branch, Chinese Medical Association. Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2018[J]. Zhonghua Shen Jing Ke Za Zhi, 2018, 51:666-682.[中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2018[J]. 中华神经科杂志, 2018, 51:666-682.] [12] Lyden P, Raman R, Liu L, Grotta J, Broderick J, Olson S, Shaw S, Spilker J, Meyer B, Emr M, Warren M, Marler J. NIHSS training and certification using a new digital video disk is reliable[J]. Stroke, 2005, 36:2446-2449. [13] Mihindu E, Mohammed A, Smith T, Brinster C, Sternbergh WC 3rd, Bazan HA. Patients with moderate to severe strokes (NIHSS score > 10) undergoing urgent carotid interventions within 48 hours have worse functional outcomes[J]. J Vasc Surg, 2019, 69:1471-1481. [14] Xu L, Du XY. Changes and clinical significance of plasma homocysteine, high sensitivity C reactive protein D-D dimer and a in patients with acute cerebral infarction[J]. Nei Meng Gu Yi Ke Da Xue Xue Bao, 2017, 39:232-235.[许琳, 杜肖彦. 急性脑梗死病人血浆同型半胱氨酸、超敏C反应蛋白、D-二聚体、脂蛋白a水平的改变及临床意义[J]. 内蒙古医科大学学报, 2017, 39:232-235.] [15] Zhao DX, Qiu B, Jiang LN, Li ST, Shi BL, Zhao ZG. Changes and clinical significance of serum hypersensitive C-reactive protein homocysteine neutrophil gelatinase-associated apolipoprotein in severe patients[J]. Shanxi Yi Yao Za Zhi, 2018, 47:1763-1765.[赵东霞, 邱波, 蒋丽娜, 李树铁, 史宝林,赵自刚. 重症患者血清超敏C反应蛋白同型半胱氨酸中性粒细胞明胶酶相关载脂蛋白的变化与临床意义[J]. 山西医药杂志, 2018, 47:1763-1765.] [16] Jiang YL. Correlation between serum hypersensitive c-reactive protein and acute cerebral infarction[J]. Anhui Yi Yao, 2021, 25:1024-1026.[江艳柳. 血清超敏C反应蛋白与急性脑梗死的相关性研究[J]. 安徽医药, 2021, 25:1024-1026.] [17] Xu XL, Yu YF, Liu ZH, Wang W, Fu CR, Fu FJ. Value of contrast-enhanced ultrasound quantitative parameters combined with homocysteine and high-sensitivity C-reactive protein in predicting ischemic stroke[J]. Guo Ji Shen Jing Bing Xue Shen Jing Wai Ke Xue Za Zhi, 2019, 46:145-149.[徐小兰, 余岳芬,刘振华, 王薇, 符春荣, 符芳婧. 超声造影定量参数联合同型半胱氨酸及超敏C-反应蛋白对缺血性脑卒中的预测价值[J].国际神经病学神经外科学杂志, 2019, 46:145-149.] [18] Wang Y, An YC, Zhao XJ, Gao SL, Wang DL. Inflammatory markers for short-term prognosis of acute cerebral infarction[J]. Zhonghua Lao Nian Yi Xue Za Zhi, 2015, 34:44-46.[王艳, 安雅臣, 赵晓晶, 高素玲, 王大力. 炎性标记物对急性脑梗死患者早期预后的影响[J]. 中华老年医学杂志, 2015, 34:44-46.] [19] Han X, Gao YJ, Zhao SJ. The relationship between serum levels of pentraxin 3, high sensitivity c-reactive protein and the severity, prognosis of patients with acute cerebral infarction[J]. Zu Zhong Yu Shen Jing Ji Bing, 2019, 26:22-26.[韩雪, 高燕军, 赵士娇. 血清正五聚蛋白3、超敏C反应蛋白水平与急性脑梗死患者的病情严重程度及预后的关系[J]. 卒中与神经疾病, 2019, 26:22-26.] [20] Niu ZB, Zhang GH. Analysis of serum hs-CRP level and influencing factors in patients with new diabetes mellitus[J]. Hebei Yi Yao, 2016, 38:93-95.[钮忠波, 张桂红. 新发糖尿病患者血清hs-CRP水平及影响因素分析[J]. 河北医药, 2016, 38:93-95.] [21] Goldstein LB, Samsa GP. Reliability of the National Institutes of Health Stroke Scale:extension to non-neurologists in the context of a clinical trial[J]. Stroke, 1997, 28:307-310. [22] Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J, Spilker J, Holleran R, Eberle R, Hertzberg V. Measurements of acute cerebral infarction:a clinical examination scale[J]. Stroke, 1989, 20:864-870. [23] Mar J, Masjuan J, Oliva-Moreno J, Gonzalez-Rojas N, Becerra V, Casado MÁ, Torres C, Yebenes M, Quintana M, Alvarez-Sabín J; CONOCES Investigators Group. Outcomes measured by mortality rates, quality of life and degree of autonomy in the first year in stroke units in Spain[J]. Health Qual Life Outcomes, 2015, 13:36. |